FDA — authorised 7 June 2001
- Application: NDA021074
- Marketing authorisation holder: SOLVENTUM
- Local brand name: AVAGARD
- Indication: SOLUTION — TOPICAL
- Status: approved
FDA authorised Avagard on 7 June 2001
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 7 June 2001; FDA has authorised it.
SOLVENTUM holds the US marketing authorisation.